2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
3
Renal Insufficiency, Chronic
2
Prostatic Neoplasms
2
Uterine Prolapse
1
Urologic Neoplasms
1
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neuromuscular Blockade
1
Muscle Hypotonia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Melanoma
1
Lung Neoplasms
1
Leiomyoma
1
Intraabdominal Infections
1
Intestinal Obstruction
1
Interventions
Fluorouracil
498
Bevacizumab
476
Oxaliplatin
450
Leucovorin
442
Irinotecan
408
Cetuximab
318
Capecitabine
317
pembrolizumab
142
Folfox protocol
128
Panitumumab
117
regorafenib
105
Colonoscopy
88
Nivolumab
82
IFL protocol
81
Drug Therapy
77
trifluridine tipiracil drug combination
73
Radiotherapy
66
HMPL-013
65
Blood Specimen Collection
52
Gemcitabine
49
Specimen Handling
47
Standard of Care
45
Neoadjuvant Therapy
45
Magnetic Resonance Spectroscopy
44
Biopsy
44
Chemotherapy, Adjuvant
41
Trifluridine
40
atezolizumab
39
Cyclophosphamide
39
Surveys and Questionnaires
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Rocuronium
×
Clear all
NCT02327494
2015-01-07
OXYMUBLOC
Hospital Universitari de Bellvitge
Unknown
70 enrolled